GlassScriptPhysician profile
Clem Kirkland
NPI 1356431639
$11,794.96
in general payments reported to CMS, 2019-2025
35 companies · $1,613 in 2025
The $1,613 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,793 · 2020: $1,406 · 2021: $1,332 · 2022: $1,956 · 2023: $1,888 · 2024: $1,807 · 2025: $1,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,308.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,379.86 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,544.62 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $1,093.55 | 2022-2025 | |
| Abbvie INC. | $954.71 | 2021-2025 | |
| Pfizer INC. | $654.54 | 2019-2025 | |
| Amgen INC. | $581.20 | 2019-2025 | Evenity, Prolia |
| Novartis Pharmaceuticals Corporation | $569.57 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $410.71 | 2024 | Voquezna |
| Allergan, INC. | $395.81 | 2019-2020 | |
| Medtronic, INC. | $310.37 | 2022-2023 | Inpen Smart Insulin Delivery System |
| Esperion Therapeutics, INC. | $175.01 | 2020-2022 | |
| Astellas Pharma US INC | $163.09 | 2019-2023 | Veozah |
| Si-Bone, INC. | $162.42 | 2022 | |
| Glaxosmithkline, LLC. | $161.62 | 2023-2024 | Shingrix, Arexvy, Bexsero |
| Teva Pharmaceuticals USA, INC. | $160.16 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $153.06 | 2020-2024 | Mounjaro, Zepbound, Jardiance |
| Axsome Therapeutics, INC. | $134.90 | 2025 | Symbravo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.22 | 2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $119.57 | 2019-2024 | Xarelto |
| Ethicon INC. | $81.54 | 2021 | |
| Amarin Pharma, INC. | $75.19 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $71.50 | 2019 | |
| Leo Pharma INC. | $48.97 | 2019-2023 | Adbry |
| Exact Sciences Corporation | $42.80 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $40.18 | 2021 | |
| Merck Sharp & Dohme LLC | $39.99 | 2019-2022 | |
| Galderma Laboratories, L.P. | $29.06 | 2019-2021 | |
| Corcept Therapeutics | $19.05 | 2024 | Korlym |
| Seqirus USA INC | $18.93 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.17 | 2021 | |
| Epi Health, LLC | $13.74 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.00 | 2019 | |
| Sun Pharmaceutical Industries INC. | $12.45 | 2019 | |
| Smith+Nephew, INC. | $11.90 | 2022 | |
| Daiichi Sankyo INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clem Kirkland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.